Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Confident of Market Turnaround, MDS Proteomics Plans IPO for 2002

Confident of Market Turnaround, MDS Proteomics Plans IPO for 2002

Dec 17, 2001
Premium

MDS Proteomics plans to go through with an initial public offering next year to acquire additional funding, the company’s new CFO said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Not Quite There Yet

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

Call for Open Science

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Accolades for a New University

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

Nucleic Acids Research Papers on IndiGenomes, DockCoV2, ViruSurf Databases

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Nov
17
Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Sponsored by
ACD

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

What's Popular?

In Proteomics & Protein Research

  1. Biodesix Prices $72M IPO

  2. COVID-19 Multiomic Immune Response Study Reveals Differences in Disease Progression, Severity

  3. Waters Q3 Revenues Up 3 Percent

  4. Human Proteome Project Hits 90 Percent Coverage of Predicted Proteins

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.